Takeda has returned to BridGene Biosciences for another small-molecule collaboration—this time focused on immunology as well as neurology. BridGene’s pursuit of undruggable targets is enabled ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback